# A Study of LY2189265 in Japanese Participants With Type 2 Diabetes Mellitus

> **NCT01558271** · PHASE3 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 492 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** LY2189265
- **DRUG:** Placebo
- **DRUG:** Liraglutide

## Key facts

- **NCT ID:** NCT01558271
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2013-10
- **Final completion:** 2014-05
- **Target enrollment:** 492 (ACTUAL)
- **Last updated:** 2015-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01558271

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01558271, "A Study of LY2189265 in Japanese Participants With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01558271. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*